BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3436616)

  • 21. Stimulatory effect of pentagastrin on growth hormone and prolactin secretion in normal subjects.
    Altomonte L; Zoli A; Mirone L; Ghirlanda G; Bertoli A; Manna R; Greco AV
    Exp Clin Endocrinol; 1986 Dec; 88(3):334-8. PubMed ID: 3556418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine inhibits growth hormone and prolactin secretion in the human newborn.
    De Zegher F; Van Den Berghe G; Devlieger H; Eggermont E; Veldhuis JD
    Pediatr Res; 1993 Nov; 34(5):642-5. PubMed ID: 8284103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent GHRH-induced PRL secretion in Cushing's syndrome, obesity and exogenous hypercortisolism.
    Cordido F; Peino R; Martínez-Ramonde T
    Rev Esp Fisiol; 1994 Sep; 50(3):139-43. PubMed ID: 7886270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of erythropoietin administration on prolactin secretion in normal subjects.
    Bernini GP; Mariotti F; Brogi G; Cerri F; Santoni M; Ciardella F; Franchi F
    Nephron; 1993; 65(4):522-6. PubMed ID: 8302403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
    J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fenfluramine oral administration on serum prolactin levels in healthy and hyperprolactinemic women.
    Scarduelli C; Mattei AM; Brambilla G; Zavaglia C; Adelasco P; Cavioni V; Ferrari C
    Gynecol Obstet Invest; 1985; 19(2):92-6. PubMed ID: 3988149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of prolactin and growth hormone secretion in mice by obesity.
    Sinha YN; Salocks CB; Vanderlaan WP
    Endocrinology; 1976 Sep; 99(3):881-6. PubMed ID: 782857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women.
    Giusti M; Carraro A; Porcella E; Valenti S; Nicora D; Sessarego P; Giordano G
    Psychoneuroendocrinology; 1993; 18(1):79-84. PubMed ID: 8475226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K; Inoue S; Numata K; Okazaki H; Nakamura S; Takamura Y
    Metabolism; 1990 Sep; 39(9):892-6. PubMed ID: 2118219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of human galanin on growth hormone prolactin, and antidiuretic hormone secretion in normal men.
    Murakami Y; Ohshima K; Mochizuki T; Yanaihara N
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1436-8. PubMed ID: 7521348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute effects of exercise on prolactin and growth hormone secretion: comparison between sedentary women and women runners with normal and abnormal menstrual cycles.
    Chang FE; Dodds WG; Sullivan M; Kim MH; Malarkey WB
    J Clin Endocrinol Metab; 1986 Mar; 62(3):551-6. PubMed ID: 3080465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children.
    Bellone J; Bartolotta E; Cardinale G; Arvat E; Cherubini V; Aimaretti G; Maccario M; Mucci M; Camanni F; Ghigo E
    J Endocrinol Invest; 1993; 16(7):521-5. PubMed ID: 8227981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis.
    Scacchi M; Orsini F; Cattaneo A; Grasso A; Filippini B; Pecori Giraldi F; Fatti LM; Moro M; Cavagnini F
    Eur J Endocrinol; 2010 Aug; 163(2):201-6. PubMed ID: 20460421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.